Showing results (351-360 of 531) with videos related to

Sort By:
Pageof 54
The Canadian Journal of Cardiology|July 13, 2024
Results of the COMPASS Trial Analyzed Using Win Ratio Compared With Conventional Analytic ApproachesJohn W Eikelboom, Qilong Yi, William F McIntyre, et al.
JAMA Cardiology|October 2, 2024
Amiodarone or Implantable Cardioverter-Defibrillator in Chagas Cardiomyopathy: The CHAGASICS Randomized Clinical TrialMartino Martinelli-Filho, José A Marin-Neto, Mauricio Ibrahim Scanavacca, et al.
Glycobiology|May 22, 2007
Pectin induces apoptosis in human prostate cancer cells: correlation of apoptotic function with pectin structureCrystal L Jackson, Tina M Dreaden, Lisa K Theobald, et al.
European Journal of Heart Failure|February 24, 2007
Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programmeNathaniel M Hawkins, Duolao Wang, John J V McMurray, et al.
Heart (British Cardiac Society)|September 6, 2006
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programmeN M Hawkins, D Wang, J J V McMurray, et al.
The American Journal of Cardiology|September 28, 2011
Usefulness of the admission electrocardiogram to predict long-term outcomes after non-ST-elevation acute coronary syndrome (from the FRISC II, ICTUS, and RITA-3 [FIR] Trials)Peter Damman, Lene Holmvang, Jan G P Tijssen, et al.
American Heart Journal|October 8, 2013
Learning from recent trials and shaping the future of acute heart failure trialsRobert J Mentz, Gary Michael Felker, Tariq Ahmad, et al.
JACC. Cardiovascular Interventions|February 25, 2012
Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) TrialsPeter Damman, Nan van Geloven, Lars Wallentin, et al.
JACC. Advances|January 29, 2026
Empagliflozin in Heart Failure and Previous Coronary Revascularization: Insights From EMPEROR-PooledNitish K Dhingra, Javed Butler, Stefan D Anker, et al.
European Journal of Heart Failure|March 5, 2024
Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programmeJoão Pedro Ferreira, Milton Packer, Naveed Sattar, et al.
Pageof 54